MIPS Seminar: Prostate Cancer beyond PSMA: Quo Vadis GRPR

When:
May 25, 2022 @ 11:00 am – 12:00 pm
2022-05-25T11:00:00-07:00
2022-05-25T12:00:00-07:00
Where:
Zoom - see description for details
Cost:
Free
Contact:
Ashley Williams
MIPS Seminar: Prostate Cancer beyond PSMA: Quo Vadis GRPR @ Zoom - see description for details

“Prostate Cancer beyond PSMA: Quo Vadis GRPR”

 

Andrei Iagaru, MD
Division Chief of Nuclear Medicine and Molecular Imaging, Sanford Health Care
Professor of Radiology, Stanford University

 

Location: Zoom Webinar
Webinar URL: https://stanford.zoom.us/s/91781590295
Dial: +1 650 724 9799 or +1 833 302 1536
Webinar ID: 917 8159 0295
Passcode: 750639

 

ABSTRACT
Novel radiopharmaceuticals for PET are being evaluated for the diagnosis of prostate cancer. Gastrin-releasing peptide receptor (GRPR) -targeting radiopharmaceuticals are not as widely accepted as the prostate-specific membrane antigen (PSMA)-targeting ones. However, GRPR still are a valuable class of radiopharmaceuticals even when compared with PSMA in the evaluation of prostate cancer. The presentation will provide data to support this statement.

 

ABOUT DR. IAGARU
Dr. Iagaru is a Professor of Radiology – Nuclear Medicine and the Chief of the Division of Nuclear Medicine and Molecular Imaging at Stanford University Medical Center. He completed medical school at Carol Davila University of Medicine, Bucharest, Romania, and an internship at Drexel University College of Medicine, Graduate Hospital, in the Department of Medicine in Philadelphia. He began his residency at the University of Southern California (USC) Keck School of Medicine, Los Angeles, in the Division of Nuclear Medicine, where he was the chief resident. Dr. Iagaru finished his residency and completed a PET/CT fellowship at Stanford University’s School of Medicine in the Division of Nuclear Medicine. His research interests include PET/MRI and PET/CT for early cancer detection; clinical translation of novel PET radiopharmaceuticals; peptidebased diagnostic imaging and therapy; targeted radionuclide therapy.

Over the past 14 years since joining the faculty at Stanford, Dr. Iagaru has received several awards including the Society of Nuclear Medicine (SNM) 2009 Image of the Year Award; AuntMinnie 2016 Best Radiology Image, American College of Nuclear Medicine (ACNM) Mid-Winter Conference 2010 Best Essay Award; 2009, 2014 and 2015 Western Regional SNM Scientist Award; 2011 SNM Nuclear Oncology Council Young Investigator Award; and the 2020 Sanjiv Sam Gambhir Distinguished Scientist Award, Western Regional SNM. Dr. Iagaru published more than 200 papers in peer-reviewed journals, as well as 7 book chapters and 1 book.

 

Hosted by: Katherine Ferrara, PhD
Sponsored by: Molecular Imaging Program at Stanford & the Department of Radiology